Role of Mitochondrial Dysfunction in Parkinson's Disease: Implications for Treatment

Author： Ramsey Chenere P. Giasson Benoit I.

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.2, 2007-01, pp. : 95-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of Dopamine in Learning and Memory: Implications for the Treatment of Cognitive Dysfunction in Patients With Parkinson's Disease

By Kulisevsky J.

Drugs & Aging, Vol. 16, Iss. 5, 2000-05 ,pp. : 365-379

Adis International

Access to resources Recommend Favorite

Role and Treatment of Mitochondrial DNA-Related Mitochondrial Dysfunction in Sporadic Neurodegenerative Diseases

Current Pharmaceutical Design, Vol. 17, Iss. 31, 2011-10 ,pp. : 3356-3373

Bentham Science Publishers

Access to resources Recommend Favorite

By Borges N.

Drug Safety, Vol. 26, Iss. 11, 2003-01 ,pp. : 743-747

Adis International

Access to resources Recommend Favorite

Role of Infection in the Pathogenesis of Alzheimer's Disease: Implications for Treatment

By Holmes Clive Cotterell Darren

CNS Drugs, Vol. 23, Iss. 12, 2009-12 ,pp. : 993-1002

Adis International

Access to resources Recommend Favorite

The Role of Dopamine Agonists in the Treatment of Depression in Patients with Parkinson's Disease: A Systematic Review

By Leentjens Albert F.G.

Drugs, Vol. 71, Iss. 3, 2011-02 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite